CAR T-Cell Therapy Tops ASCO’s Cancer Advances – MedPage Today
MedPage Today |
CAR T-Cell Therapy Tops ASCO's Cancer Advances
MedPage Today For its transformative impact on incurable hematologic malignancies, chimeric antigen receptor (CAR) T-cell therapy earned recognition as the Advance of the Year in the American Society of Clinical Oncology (ASCO) Annual Report. Different versions of … |
